|
- 2016
Omalizumab for chronic urticaria in Latin AmericaDOI: 10.1186/s40413-016-0127-y Keywords: Omalizumab, Chronic urticaria, Anti-IgE, Real life study, Latin America Abstract: Chronic urticaria (CU) is defined as the spontaneous appearance of wheals, with or without angioedema, persisting for ≥6 weeks. Chronic Spontaneous Urticaria (CSU) is a type of CU which affects 0.5–1 % of the global population, but it represents a high burden to patients. In recent years, omalizumab is available as treatment of disease. Our aim is to extend previous findings, analyzing effects of omalizumab on symptoms in Latin American patients with CSU
|